Mar 15, 2023 / 04:40PM GMT
Frank Brisebois - Oppenheimer & Co. Inc. - Analyst
Okay. Great. Thank you. My name is Frank Brisebois. I'm one of the biotech analysts here at Oppenheimer. Thanks for joining us on day three of the conference. Even if I know everyone's been fairly extremely busy with the fund markets these days.
So with that, thank you very much, Eric, for taking the time here. So we'll have -- the next company presenting is Molecular Templates. And we'll have Eric Poma. He's the CEO of the company to present. And then if we have a little time at the end, we're going throw in some Q&A. So feel free to hit the icon on your window and send in some questions. I'll try my best to get to them. But we'll get right to it here.
Eric, thanks for joining. I'll let you take it away.
Eric Poma - Molecular Templates, Inc. - CEO & Chief Scientific Officer
Great, man. Thanks for a great conference and for letting us have the opportunity to present. I'll make forward-looking statements here. But for those of you who don't know, we've been working, at Molecular
Molecular Templates Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers